Evaluation of Antibody Parameters as Potential Correlates of Protection or Enhancement by Experimental Vaccines to Equine Infectious Anemia Virus
- 1 September 1999
- Vol. 262 (2) , 416-430
- https://doi.org/10.1006/viro.1999.9939
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- In Vitro Antibody-Dependent Enhancement Assays Are Insensitive Indicators of in Vivo Vaccine Enhancement of Equine Infectious Anemia VirusVirology, 1999
- Immunization with a Recombinant Envelope Protein (rgp90) of EIAV Produces a Spectrum of Vaccine Efficacy Ranging from Lack of Clinical Disease to Severe EnhancementVirology, 1998
- Production of monoclonal antibodies to six isotypes of horse immunoglobulinVeterinary Immunology and Immunopathology, 1998
- Infected Macaques That Controlled Replication of SIVmacor Nonpathogenic SHIV Developed Sterilizing Resistance against Pathogenic SHIVKU-1Virology, 1997
- Fine specificity of equine infectious anaemia virus gp90-specific antibodies associated with protective and enhancing immune responses in experimentally infected and immunized poniesJournal of General Virology, 1996
- The immunopathogenesis of equine infectious anemia virusVirus Research, 1994
- Enhancement of EIAV Replication and Disease by Immunization with a Baculovirus-Expressed Recombinant Envelope Surface GlycoproteinVirology, 1994
- In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV)Archiv für die gesamte Virusforschung, 1990
- Lentivirus antigen purification and characterization: isolation of equine infectious anemia virus gag and env proteins in one step by reverse phase HPLC and application to human immunodeficiency virus glycoproteinsJournal of Virological Methods, 1988
- Isolation of equine infectious anemia virus glycoproteins. Lectin affinity chromatography procedures for high avidity glycoproteinsJournal of Virological Methods, 1983